Can we cure autoimmunity?

Area of Science:

• Immunology
• Autoimmune Diseases
• Therapeutic Strategies

Background:

• Traditional autoimmune disease treatments rely on broad immunosuppression.
• Emerging targeted therapies, like monoclonal antibodies, also induce significant immunosuppression.
• Current 'remission' states often necessitate continuous immunosuppressive therapy, which is not an ideal long-term solution.

Purpose of the Study:

• To define and explore the concept of a 'cure' for autoimmune diseases.
• To discuss potential mechanisms and obstacles in achieving a cure.
• To examine cure possibilities in systemic lupus erythematosus (SLE) and type 1 diabetes (T1D) as representative models.

Main Methods:

• Conceptual analysis of 'cure' versus 'remission' in autoimmunity.
• Review of current and emerging therapeutic strategies.
• Comparative discussion of challenges in systemic vs. organ-specific autoimmune diseases.

Main Results:

• A cure is defined as disease resolution without the need for ongoing immunosuppressive therapy.
• Achieving a cure is highly complex and disease-specific.
• Progress towards a cure necessitates a detailed understanding of immune cell subsets and preclinical pathology.

Conclusions:

• A cure for autoimmunity, distinct from sustained remission, is a challenging but crucial goal.
• Understanding the distinct pathologies of systemic (e.g., SLE) and organ-specific (e.g., T1D) autoimmune diseases is vital for developing curative strategies.
• Further research into immune cell subsets and early disease detection is essential for advancing towards a cure.